The Gross Margin of Sprint Bioscience AB (SPRINT.ST) is 56.83%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 56.83% |
2023-12-31 | 82.77% |
2022-12-31 | -15478.31% |
2021-12-31 | 70.28% |
2020-12-31 | 38.06% |
2019-12-31 | 75.63% |
2018-12-31 | 41.89% |
2017-12-31 | 87.53% |
2016-12-31 | 98.80% |
2015-12-31 | 102.69% |